In view of the plans made by national health authorities in every country across the world for the widespread vaccination of individuals against the SARS-CoV-2 virus, the Thalassaemia International Federation herein presents the latest information concerning the to-date authorized vaccinations, as well as the Federation’s position about the vaccination of patients with haemoglobin disorders against SARS-CoV-2.
Blood Supply Challenges & Transfusion Care of Patients With Haemoglobinopathies During COVID-19 Pandemic
janvier 22, 2021
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System
avril 1, 2021
septembre 12, 2020